Evidence map›Paper›PMID 34037418›Full record

ArticleJournal of virology2021

Inhibition of PARP1 Dampens Pseudorabies Virus Infection through DNA Damage-Induced Antiviral Innate Immunity.

Guo-Li Li, Guang-Xu Ding, Lei Zeng, Sheng-Li Ming, Peng-Fei Fu, Qi Wang, Guo-Yu Yang, Jiang Wang, Bei-Bei Chu

Open access · greenAbstract read
In one paragraph

Article in Journal of virology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Identification of porcine PARP11 as a restricted factor for pseudorabies virus.Frontiers in cellular and infection microbiology · 2024
    Article
  6. Therapeutic and immune-regulation effects ofFrontiers in veterinary science · 2024
    Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Guo-Li Li *College of Veterinary Medicine, Henan Agricultural University, Zhengzhou, Henan Province, People's Republic of China.
Guang-Xu Ding *College of Veterinary Medicine, Henan Agricultural University, Zhengzhou, Henan Province, People's Republic of China.
Lei ZengCollege of Veterinary Medicine, Henan Agricultural University, Zhengzhou, Henan Province, People's Republic of China.
Sheng-Li MingCollege of Veterinary Medicine, Henan Agricultural University, Zhengzhou, Henan Province, People's Republic of China.
Peng-Fei FuCollege of Veterinary Medicine, Henan Agricultural University, Zhengzhou, Henan Province, People's Republic of China.
Qi WangCollege of Veterinary Medicine, Henan Agricultural University, Zhengzhou, Henan Province, People's Republic of China.
Guo-Yu YangCollege of Veterinary Medicine, Henan Agricultural University, Zhengzhou, Henan Province, People's Republic of China.
Jiang WangCollege of Veterinary Medicine, Henan Agricultural University, Zhengzhou, Henan Province, People's Republic of China.
Bei-Bei ChuCollege of Veterinary Medicine, Henan Agricultural University, Zhengzhou, Henan Province, People's Republic of China.
Ministry of Agriculture and Rural Affairs · CN

Funding

Natural Science Foundation of Henan 202300410213Outstanding Talents of Henan Agricultural University 30600773Ten Thousand Talents Program for Young Talents W03070106
6 · The paper itself

Abstract

Pseudorabies virus (PRV) is the causative pathogen of Aujeszky's disease in pigs. Although vaccination is currently applied to prevent the morbidity of PRV infection, new applications are urgently needed to control this infectious disease. Poly(ADP-ribose) polymerase 1 (PARP1) functions in DNA damage repair. We report here that pharmacological and genetic inhibition of PARP1 significantly influenced PRV replication. Moreover, we demonstrate that inhibition of PARP1 induced DNA damage response and antiviral innate immunity. Mechanistically, PARP1 inhibition-induced DNA damage response resulted in the release of double-stranded DNA (dsDNA) into the cytosol, where dsDNA interacted with cyclic GMP-AMP (cGAMP) synthase (cGAS). cGAS subsequently catalyzed cGAMP production to activate the STING/TBK1/IRF3 innate immune signaling pathway. Furthermore, challenge of mice with PARP1 inhibitor stimulated antiviral innate immunity and protected mice from PRV infection

Indexed as

AnimalsAntiviral AgentsCell LineDNA DamageHerpesvirus 1, SuidHumansImmunity, InnateMembrane ProteinsMiceNucleotidyltransferasesPoly (ADP-Ribose) Polymerase-1Poly(ADP-ribose) Polymerase InhibitorsPseudorabiesSignal TransductionSwineVirus ReplicationAntiviral AgentsMembrane ProteinsNucleotidyltransferasesPoly (ADP-Ribose) Polymerase-1Poly(ADP-ribose) Polymerase Inhibitorscyclic GMP-AMP synthaseDNA damageinnate immunitypoly(ADP-ribose) polymerase 1pseudorabies virusstimulator of interferon genes

Identifiers

PMID34037418
PMCPMC8312877
OpenAlexW3165679768

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.